
Johnson & Johnson has agreed to purchase clinical-stage biotechnology firm Halda Therapeutics for $3.05 billion in money in a deal that bolsters the healthcare big’s oncology pipeline.
Source link


Johnson & Johnson has agreed to purchase clinical-stage biotechnology firm Halda Therapeutics for $3.05 billion in money in a deal that bolsters the healthcare big’s oncology pipeline.
Source link
:max_bytes(150000):strip_icc()/HDC-GettyImages-668641904-9179dc9fe60446d8b4d8a08fbffcf46d.jpg?w=600&resize=600,400&ssl=1)


:max_bytes(150000):strip_icc():format(jpeg)/Health-GettyImages-1484341547-2b72e64020e84487bb504cbe25299d4e.jpg?w=600&resize=600,400&ssl=1)

Recent Comments